Published in Volume
122, Issue 2 (February 1, 2012)
J Clin Invest. 2012;122(2):780–780.
doi:10.1172/JCI62812.
Copyright © 2012, American Society for Clinical
Investigation
Corrigendum
CD2AP in mouse and human podocytes controls a proteolytic program
that regulates cytoskeletal structure and cellular survival
Suma Yaddanapudi, Mehmet M. Altintas, Andreas D. Kistler, Isabel Fernandez, Clemens C. Möller, Changli Wei, Vasil Peev, Jan B. Flesche, Anna-Lena Forst, Jing Li, Jaakko Patrakka, Zhijie Xiao, Florian Grahammer, Mario Schiffer, Tobias Lohmüller, Thomas Reinheckel, Changkyu Gu, Tobias B. Huber, Wenjun Ju, Markus Bitzer, Maria P. Rastaldi, Phillip Ruiz, Karl Tryggvason, Andrey S. Shaw, Christian Faul, Sanja Sever and Jochen Reiser
Published February 1, 2012
Original citation: J. Clin. Invest. 2011;121(10):3965–3980.
doi:10.1172/JCI58552.
Citation for this corrigendum: J. Clin. Invest. 2012;122(2):780.
doi:10.1172/JCI62812.
During the preparation of this manuscript, the fourth row of images in Figure 5C was inadvertently mislabeled. The figure is
correctly labeled below.
The authors regret the error.
